Real-time enrollment status for this pompe disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT03911505 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Pompe Disease |
| Phase | Clinical Trial |
| Target Enrollment | 22 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Amicus Therapeutics |
| Last Updated on CT.gov | October 27, 2025 (Oct 27, 2025) |
As of March 2, 2026: Clinical trial NCT03911505 is currently active_not_recruiting participants. This clinical trial study for pompe disease is not currently accepting new participants at 14 locations across the United States. The study is sponsored by Amicus Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03911505 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03911505 was last updated Oct 27, 2025 (October 27, 2025). HelloStudys verifies this status automatically.